On February 24, 2025, Deborah Macdonald notified Kinder Morgan, Inc. (“KMI”) that she will retire from KMI’s Board of Directors (the “Board”) at the end of her current term and consequently will not stand for re-election to the Board at KMI’s 2025 annual meeting of stockholders in May (the “2025 Annual Meeting”).
On February 25, 2025, the Board of Directors (the “Board”) of Louisiana-Pacific Corporation (the “Company”) appointed Kelly H. Barrett as a director of the Company.
On February 26, 2025, John V. Priore provided to the Board of Directors (the “Board”) notification of his resignation from the Board of Priority Technology Holdings, Inc. (the “Company”), effective April 1, 2025.
On February 27, 2025, the Board of Directors filled the vacancy created by Mr. Morgan’s retirement by appointing Rob Buchner as a Class III member of the Board of Directors.
Departed
Charles Morgan
Class III member of the Board of Directors; Lead Independent Director; Chairman of the Nominating and Corporate Governance Committee; member of the Audit Committee
On February 27, 2025, Charles Morgan notified the Company of his retirement, effective immediately, from his position as a Class III member of the Company’s Board of Directors and from his positions as Lead Independent Director, Chairman of the Nominating and Corporate Governance Committee and member of the Audit Committee.
Matthew McIlwain agreed to resign as a Class II director, effective as of the opening of the polls for the election of Class I directors at the Annual Meeting, and to stand for election to the Board as a Class I director at the Annual Meeting
On February 25, 2025, the Board of Directors of Camden National Corporation (the “Company”) increased the size of the Company’s Board of Directors (the “Board”) to 12 members and elected Ms. Raina Maxwell to fill the vacancy created upon the increase in the size of the Board, in each case, effective February 25, 2025.
On February 24, 2025, Jonathan R. Scott, an incumbent Class I director who is serving on the board of directors of the registrant (the “Board”) as one of three Scott family members previously designated by the Scott family to be nominated for election to serve on the Board pursuant to a stockholders’ agreement between the registrant and members of the Scott family (the “Stockholders’ Agreement”), informed the Board of his decision to not seek to stand for re-election at the 2025 annual meeting of stockholders of the registrant (the “2025 Annual Meeting”).
On February 24, 2025, Bill Wagner, a member of the Board of Directors (the “Board”) of Akamai Technologies, Inc. (the “Company”), notified the Company of his intent to resign from the Board, effective immediately, due to his acceptance of a new role as Chief Executive Officer of Semrush Holdings, Inc.
James Ramsey, an independent member of the Board, advised the Company that he will not stand for re-election to the Board at the Company's 2025 annual meeting of stockholders and intends to retire from the Board at that time.
Effective February 26, 2025, The Goldman Sachs Group, Inc. (the Registrant) appointed KC McClure as an independent member of the Registrant’s Board of Directors.
Effective February 26, 2025, the Board of Directors of Fortive Corporation (the “Company”) increased the size of the Company’s Board from nine to ten members and appointed Gregory J. Moore, M.D., Ph.D., to the Board
On February 26, 2025, Sean Ward resigned from his position as Senior Managing Director of Blue Owl Capital Inc. (the “Company”) and as a member of the Board of Directors of the Company.
Departed
Niccolo de Masi
Member of the Board of Directors
dMY Squared Technology Group, Inc.
Effective
2025-02-26
Filed
February 26, 2025, 6:59 PM ET
On February 26, 2025, Niccolo de Masi, an officer and a member of the Board of Directors (the “Board”) of dMY Squared Technology Group, Inc. (the “Company”), notified the Company of his decision to resign as Chief Executive Officer of the Company and as a member of the Board, effective immediately, in order to pursue another opportunity.
On February 26, 2025, the Boards of Directors of First Northwest Bancorp (the "Company") and its banking subsidiary, First Fed Bank ("First Fed"), announced approval of the election of Johanna A. Bartee as a Director, filling the vacancy created by Craig Curtis' departure in December 2024.
On February 26, 2025, AIM ImmunoTech Inc. (the "Company") issued a press release announcing the appointment of David I. Chemerow to its Board of Directors (the "Board"), effective February 24, 2025
On February 20, 2025, Anita Pramoda informed the Board of her resignation from the Board, and on February 20, 2025, the Board accepted her resignation, including her resignation from the compensation committee and transactions committee of the Board, effective March 1, 2025.
Mr. Cornick informed the Board that he will not stand for re-election as a director when his term expires at the Company’s 2025 annual meeting of shareholders.
On February 19, 2025, Sabrina Soussan and the Board of Directors of the Company decided that Ms. Soussan would not stand for re-election at the Company’s 2025 Annual Meeting of Shareholders.
On February 19, 2025, Suzanne P. Nimocks notified the Board of Directors (the “Board”) of Ovintiv Inc. (the “Corporation”) that she will not stand for re-election as a director of the Corporation at the Corporation’s 2025 Annual Meeting of Shareholders.
On February 24, 2025, the Board of Directors (the “Board”) of CONMED Corporation (the “Company”) increased the size of the Board to nine directors and appointed Mark Kaye as a director effective immediately.
On February 25, 2025, Gerard Cunningham notified the Board of Directors (the “Board”) and the Corporate Secretary of Stem, Inc. (the “Company”) of his resignation from the Board effective February 28, 2025 for personal reasons.
On February 24, 2025, the Board of Directors (the “Board”) of Altimmune, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased its size from eight to ten directors and appointed Teri Lawver and Jerome Durso as directors of the Board.
On February 24, 2025, the Board of Directors (the “Board”) of Altimmune, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased its size from eight to ten directors and appointed Teri Lawver and Jerome Durso as directors of the Board.
As previously announced by the Company on its Current Report on Form 8-K filed on September 25, 2024, John C. Malone, a member of the Board, will not stand for reelection and will cease being a member of the Board when his current term expires at the 2025 annual meeting.
On February 19, 2025, Andrea L. Wong notified QVC Group, Inc. (the “ Company ”) that she does not intend to stand for reelection as a member of the Board of Directors (the “ Board ”) of the Company.
Directors, Mr. William McDevitt and Mr. Sanjiv Sanghvi notified the Company on February 19, 2025, that each will serve out their current term for Director until the Company's 2025 Annual Meeting of Shareholders, but will not stand for re-election at such meeting.
Directors, Mr. William McDevitt and Mr. Sanjiv Sanghvi notified the Company on February 19, 2025, that each will serve out their current term for Director until the Company's 2025 Annual Meeting of Shareholders, but will not stand for re-election at such meeting.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.